Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease.

CONCLUSIONS: The present study validated the favorable pharmacokinetic profiles of MCS and the biochemical mechanisms of MCS in treating type 2 diabetes and NAFLD. PMID: 32762728 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32762728?dopt=Abstract

Source: BMC Pharmacology and Toxicology - August 13, 2020 Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research